Add to ORKGCancer immunotherapy holds great promise, yet its efficacy and applicability can be hampered by the rise of systemic toxicities. We have recently shown that the lethal side effects of cancer immunotherapy are markedly exacerbated with aging. Blocking tumor necrosis factor α or macrophages can alleviate the systemic toxicity of immunotherapy while preserving its antineoplastic effects
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Cancer commonly occurs in the elderly and immunotherapy (IT) is being increasingly applied to this p...
Cancer commonly occurs in the elderly and immunotherapy (IT) is being increasingly applied to this p...
There is a growing list of cancer immunotherapeutics approved for use in a population with an increa...
Cancer incidence increases drastically with age. Of the many possible reasons for this, there is the...
Cancer immunotherapy has entered the forefront of cancer treatment, but major challenges still exist...
Impaired immune function has been implicated in the declining health and higher incidence of cancer ...
Immune functions decline as we age, while the incidence of cancer rises. The advent of immune checkp...
Summary: Both tumors and aging alter the immune landscape of tissues. These interactions may play an...
Nowadays, new advances in society and health have brought an increased life expectancy. However, at ...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
This thesis showed that specialised immune cells, dendritic cells and T cells, that play a key role ...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Cancer commonly occurs in the elderly and immunotherapy (IT) is being increasingly applied to this p...
Cancer commonly occurs in the elderly and immunotherapy (IT) is being increasingly applied to this p...
There is a growing list of cancer immunotherapeutics approved for use in a population with an increa...
Cancer incidence increases drastically with age. Of the many possible reasons for this, there is the...
Cancer immunotherapy has entered the forefront of cancer treatment, but major challenges still exist...
Impaired immune function has been implicated in the declining health and higher incidence of cancer ...
Immune functions decline as we age, while the incidence of cancer rises. The advent of immune checkp...
Summary: Both tumors and aging alter the immune landscape of tissues. These interactions may play an...
Nowadays, new advances in society and health have brought an increased life expectancy. However, at ...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
This thesis showed that specialised immune cells, dendritic cells and T cells, that play a key role ...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...
Aging is associated with an increased incidence of cancer. One contributing factor could be modulati...